Synthesis, characterization and anticancer activity of novel hydrazide-hydrazones derived from ethyl paraben

Abstract

Parabens, which are hydroxybenzoic acid esters, are particularly used as protective against mold and fungus. Ethyl paraben is a compound open to modification for the synthesis of new molecules due to the ester group in its structure. In this study, ethyl paraben was used as a starting material. A new series of novel hydrazide-hydrazones from derived ethyl paraben were synthesized and characterized by spectroscopic techniques such as NMR, FT-IR besides elemental analysis. In order to determine the anticancer activity of the aimed ethyl paraben hydrazidehydrazones we evaluated their cytotoxic activity on liver cancer cell line liver hepatocellular carcinoma (HepG2). Herein we described several 4-hydroxy-N'-[substituted methylidene] benzohydrazides (3a-j) as anticancer agents. We designed, synthesized and characterized the series of novel hydrazide-hydrazones from ethyl paraben. All of the compounds evaluated for anticancer activity by using MTT assay for 24 and 48 h. mRNA transcription levels of Bax, Bcl-2 and caspase-3 genes were determined by realtime polymerase chain reaction (qRT-PCR) analysis. Compounds 3i and 3j showed anticancer activity with 42.4 and 37.4 µM IC50 values, respectively. Doxorubicin was used as a positive sensitivity reference standard. qRTPCR analysis approved that there was a timedependent rise in the expression levels of Bax, Bcl-2 and Caspase 3 on apoptosis. The activities of the synthesized compounds changed depending on the dose and time of treatment and some of the molecules started to show activity within 48 hours.

Keywords

• Ethyl paraben
• hydrazide-hydrazone
• anticancer acitivity
• MTT assay
• qRT‐PCR
• HepG2.

References

1. [1] Jonkers N, Sousa, A, Galante-Oliveira, S., Barroso, C.M., Kohler, H.P.E., Giger, W. Occurrence and sources of selected phenolic endocrine disruptors in Ria de Aveiro, Portugal. Environ. Sci Pollut Res. 2017; 17: 834–843. [CrossRef]
2. [2] Liao X, Raghavan GSV, Yaylayan VA. A novel way to prepare n-butylparaben under microwave irradiation. Tetrahedron Letters. 2002; 43: 45–48. [CrossRef]
3. [3] Błędzka D, Gromadzińska J, Wąsowicz W. Parabens. From environmental studies to human health. Env Int. 2014; 67: 27–42. [CrossRef]
4. [4] Elder RL. Final report on the safety assessment of methylparaben, ethylparaben, propylparaben and butylparaben. J A Col Tox. 1984; 3(5): 147-209.
5. [5] Boberg J, Taxvig C, Christiansen S, Hass U. Possible endocrine disrupting effects of parabens and their metabolites. Rep Tox. 2010; 30: 301–312. [CrossRef]
6. [6] Smarr MM, Sundaram R, Honda M, Kannan K, Louis GMB. Urinary concentrations of parabens and other antimicrobial chemicals and their association with couples fecundity. Env Heal Persp. 2017; 125: 730-736. [CrossRef]
7. [7] Rollas S, Küçükgüzel ŞG. Biological Activities of Hydrazone Derivatives. Molecules. 2007; 12: 1910-1939. [CrossRef]
8. [8] Kömürcü ŞG, Rollas S, Ulgen M, Gorrod JW, Cevikbaş A Evaluation of some arylhydrazones of p-aminobenzoic acid hydrazide as antimicrobial agents and their in-vitro hepatic microsomal metabolism. Boll Chim Farmaceutico. 1995; 134: 375-379.

9. [9] Küçükgüzel ŞG, Rollas S, Küçükgüzel İ, Kiraz M. Synthesis and antimycobacterial activity of some coupling products from 4-aminobenzoic acid hydrazones. Eur J Med Chem. 1999; 34: 1093−1100. [CrossRef]
10. [10] Küçükgüzel ŞG, Mazi A, Sahin F, Öztürk S, Stables J. Synthesis and biological activities of diflunisal hydrazidehydrazones. Eur J Med Chem. 2003; 38: 1005-1013. [CrossRef]
11. [11] Tatar E, Küçükgüzel İ, Daelemans D, Talele TT, Kaushik-Basu N, De Clercq E, Pannecouque C. Some hydrazones of 2-aroylamino-3-methylbutanohydrazide: synthesis, molecular modeling studies, and identification as stereoselective inhibitors of HIV-1. Arch Pharm Chem Life Sci. 2013; 346: 140–153. [CrossRef]
12. [12] Tatar E, Şenkardes S, Sellitepe HE, Küçükgüzel ŞG, Karaoglu ŞA, Bozdeveci A, De Clercq E, Pannecouque P, Hadda TB, Küçükgüzel İ. Synthesis, and prediction of molecular properties and antimicrobial activity of some acylhydrazones derived from N -(arylsulfonyl)methionine. Turk J Chem. 2016; 40: 510 – 534. [CrossRef]
13. [13] Popiołek L, Biernasiuk A. Synthesis and investigation of antimicrobial activities of nitrofurazone analogues containing hydrazide-hydrazone moiety. Saudi Pharm J. 2017; 25: 1097-1102. [CrossRef]
14. [14] Çıkla P, Tatar E, Kucukguzel İ, Sahin F, Yurdakul D, Basu A, Krishnan R, Nichols DB, Basu NK, Küçükgüzel ŞG. Synthesis and characterization of flurbiprofen hydrazide derivatives as potential anti-HCV, anticancer and antimicrobial agents. Med Chem Res. 2013; 22: 5685–5699. [CrossRef]
15. [15] Çıkla P, Özsavcı D, Özakpınar ÖB, Şener A, Çevik Ö, Turan SÖ, Akbuga J, Şahin F, Küçükgüzel ŞG. Synthesis, cytotoxicity, and pro-apoptosis activity of etodolac hydrazide derivatives as anticancer agents. Arch Pharm Chem Life Sci. 2013; 346: 367–379. [CrossRef]
16. [16] Aydın S, Kaushik-Basu N, Arora P, Basu A, Nichols DB, Talele TT, Akkurt M, Çelik İ, Büyükgüngör O, Küçükgüzel ŞG. Microwave assisted synthesis of some novel Flurbiprofen hydrazide-hydrazones as anti-HCV NS5B and anticancer agents. Marmara Pharm J. 2013; 17: 181-189. [CrossRef]
17. [17] Çıkla P, Küçükgüzel ŞG, Küçükgüzel İ, Rollas S, De Clercq E, Pannecouque C, Andrei G, Snoeck R, Şahin F, Bayrak ÖF. Synthesis and evaluation of antiviral, antitubercular and anticancer activities of some novel thioureas derived from 4-aminobenzohydrazide hydrazones. Marmara Pharm J. 2010; 14: 13-20. [CrossRef]
18. [18] Küçükgüzel ŞG, Koç D, Süzgün PÇ, Özsavcı D, Özakpınar ÖB, Tiber PM, Orun O, Erzincan P, Erdem SS, Şahin F. Synthesis of tolmetin hydrazide–hydrazones and discovery of a potent apoptosis ınducer in colon cancer cells. Arch Pharm Chem Life Sci. 2015; 348: 730–742. [CrossRef]
19. [19] Şenkardes S, Kaushik-Basu N, Durmaz İ, Manvar D, Basu A, Atalay R, Küçükgüzel ŞG. Synthesis of novel diflunisal hydrazide-hydrazones as anti-hepatitis C virus agents and hepatocellular carcinoma inhibitors. Eur J Med Chem. 2016; 108: 301-308. [CrossRef]
20. [20] Keogh A, Senkardes S, Idle JR, Küçükgüzel SG, Beyoglu D. A Novel Anti-Hepatitis C virus and antiproliferative agent alters metabolic networks in HepG2 and Hep3B cells. Metabolites. 2017; 7, 23: 1-16. [CrossRef]
21. [21] Han Mİ, Bekçi H, Cumaoğlu A, Küçükgüzel ŞG. Synthesis and characterization of 1,2,4-triazole containing hydrazide-hydrazones derived from (S)-Naproxen as anticancer agents. Marmara Pharm J. 2018; 22(4): 559-569. [CrossRef]
22. [22] Han Mİ, Bekçi H, Uba Aİ, Yıldırım Y, Karasulu E, Cumaoğlu A, Karasulu HY, Yelekçi K, Yılmaz Ö, Küçükgüzel ŞG. Synthesis, molecular modeling, in vivo study and anticancer activity of 1,2,4-triazole containing hydrazidehydrazones derived from (S)-naproxen. Arch Pharm Chem Life Sci. 2019; 352 (6): 1-14. [CrossRef]
23. [23] Kaplancıklı ZA, Yurttaş L, Özdemir A, Turan-Zitouni G, Çiftci GA, Yıldırım SU, Mohsen UA. Synthesis and antiproliferative activity of new 1,5-disubstituted tetrazoles bearing hydrazone moiety. Med Chem Res. 2014; 23: 1067–1075. [CrossRef]
24. [24] Bhole RP, Bhusari KP. Synthesis, Antihypertensive Activity, and 3D-QSAR Studies of Some New pHydroxybenzohydrazide Derivatives. Arch Pharm Chem Life Sci. 2011; 2: 119–134. [CrossRef]
25. [25] Akl H, Vervloessem T, Kiviluoto S, Bittremieux M, Parys JB, De Smedt H, Bultynck G. A dual role for the antiapoptotic Bcl-2 protein in cancer: Mitochondria versus endoplasmic reticulum. Biochimica et Biophysica Acta. 2014; 1843: 2240–2252. [CrossRef]
26. [26] http://www.molinspiration.com
27. [27] Stockert JC, Blázquez-Castro A, Cañete M, Horobin R W, Villanueva A. MTT assay for cell viability: Intracellular localization of the formazan product is in lipid droplets. Acta Histochemica. 2012; 114(8): 785-796. [CrossRef]
28. [28] van Tonder A, Joubert AM, Cromarty AD. Limitations of the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2Htetrazolium bromide (MTT) assay when compared to three commonly used cell enumeration assays. BMC Research Notes. 2015; 8(47): 1-10. [CrossRef]
29. [29] Diao SL, Xu HP, Zhang B, Ma BX, Liu XL. Associations of MMP-2, BAX, and Bcl-2 mRNA and Protein Expressions with Development of Atrial Fibrillation. Medical Science Monitor. 2016; 22: 1497-1507. [CrossRef]A